A case of extensive ulcerating vasculitis following a BCG vaccination.
Adverse reactions following BCG vaccination are uncommon, with an estimated prevalance of 0.4 per 1000 vaccines [Lotte A, Wasz-Hockert O, Poisson N, et al. Second IUATLD study on complications induced by intradermal BCG vaccination. Bull Int Union Tuber 1988;63:47-59]. Complications include erythema, blistering, abscess formation, regional lymphadenitis and keloid formation. The onset of cutaneous tuberculosis (TB) has also been reported. We describe the case of 12-year-old girl who developed extensive primary ulceration involving most of her left upper arm at the site of a BCG vaccination. A skin graft to the arm failed to take at the periphery and the ulcerated area increased to involve most of the upper lateral arm. Over a period of 18 months, secondary lesions developed on her forehead prompting further investigation of a systemic disease process. Following extensive immunological and microbiological examination, a diagnosis of vaccine-induced granulomatous vasculitis was made and the patient responded to a combination of antituberculous therapy and steroids. Once the disease process was under control, skin grafting of the ulcerated area was successful in achieving wound closure. Non-healing ulceration may be referred to the plastic surgeon and a diagnosis of vasculitis should be considered in difficult cases. A multidisciplinary team approach involving immunologists, dermatologists and plastic surgeons provides the best opportunity for a successful long-term outcome in terms of disease control as well as immediate skin cover.
Ghattaura
A
A
Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK. amarghatt@hotmail.com
Eley
K A
KA
Molenaar
E
E
Smith
G
G
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D001500:BCG Vaccine / Q000009:adverse effects*; D002648:Child; D005260:Female; D005546:Forehead; D006801:Humans; D016038:Skin Transplantation / Q000379:methods; D012883:Skin Ulcer / Q000209:etiology* / Q000628:therapy; D034941:Upper Extremity / Q000473:pathology*; D014657:Vasculitis / Q000209:etiology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine